Literature DB >> 8161761

The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis.

P Nunn1, M Mungai, J Nyamwaya, C Gicheha, R J Brindle, D T Dunn, W Githui, J O Were, K P McAdam.   

Abstract

SETTING: Developing country tertiary referral hospital plus catchment community.
OBJECTIVE: To determine the infectiousness of culture-confirmed pulmonary tuberculosis in patients infected with Human Immunodeficiency Virus type-1 (HIV-1).
DESIGN: Comparison of the incidence of tuberculosis and the prevalence of tuberculin skin test positivity among the household contacts of both HIV-1 positive and negative cases with pulmonary tuberculosis.
RESULTS: Of 255 contacts of HIV-1 negative index cases, 2 were HIV-1 positive and of 102 contacts of HIV-1 positive index cases, 14 were HIV-1 positive (odds ratio (OR) = 20.0 95% Confidence Interval (CI) 4.4-193). 21 cases of tuberculosis were diagnosed among contacts, of whom 3 were HIV-1 positive. The overall unadjusted OR for tuberculosis among contacts of HIV-1 positive index cases was 1.6 (95% CI 0.6-4.3) compared to contacts of HIV-1 negative index cases. Amongst HIV-1 negative contacts alone the OR was 1.5 (95% CI 0.4-4.4). In this group the best predictors of tuberculosis among contacts were female sex of the index case (OR = 3.4 95% CI 1.1-12), sharing the same bed as the index case (OR = 2.6 95% CI 0.9-7.4), and contact's age less than 5 years (OR = 3.3 95% CI 1.1-9.5). HIV-1 positive contacts were more likely to develop tuberculosis than HIV-1 negative contacts (OR = 4.1 95% CI 0.7-17). Tuberculin skin test positivity rates were the same among the HIV-1 negative contacts of HIV-1 positive and negative index cases (OR = 1.1 CI 0.7-1.6).
CONCLUSIONS: HIV-1 associated pulmonary tuberculosis is not more infectious than tuberculosis alone. The presence of HIV-1 in a community does not mandate a change in the management of contacts of patients with pulmonary tuberculosis.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Delivery Of Health Care; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Examinations And Diagnoses; Health; Health Facilities; Hiv Infections; Hospitals; Infections; Kenya; Laboratory Examinations And Diagnoses; Physical Examinations And Diagnoses; Research Report; Tuberculosis; Viral Diseases

Mesh:

Year:  1994        PMID: 8161761     DOI: 10.1016/0962-8479(94)90098-1

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  17 in total

1.  The impact of HIV/AIDS on the control of tuberculosis in India.

Authors:  B G Williams; R Granich; L S Chauhan; N S Dharmshaktu; C Dye
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

2.  Occult miliary tuberculosis in advanced HIV disease.

Authors:  E L Corbett; R N Davidson; S B Lucas; N Shetty; R F Miller
Journal:  Genitourin Med       Date:  1996-06

3.  Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.

Authors:  Rinat Sergeev; Caroline Colijn; Megan Murray; Ted Cohen
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

4.  Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986-1996.

Authors:  J A Odhiambo; M W Borgdorff; F M Kiambih; D K Kibuga; D O Kwamanga; L Ng'ang'a; R Agwanda; N A Kalisvaart; O Misljenovic; N J Nagelkerke; M Bosman
Journal:  Am J Public Health       Date:  1999-07       Impact factor: 9.308

Review 5.  Tropical respiratory medicine. 2. Impact of human immunodeficiency virus on tuberculosis in developing countries.

Authors:  P P Nunn; A M Elliott; K P McAdam
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

Review 6.  An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa.

Authors:  A D Harries; D Maher; P Nunn
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

Review 7.  Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration.

Authors:  Jacqueline M Achkar; Stephen D Lawn; Mahomed-Yunus S Moosa; Colleen A Wright; Victoria O Kasprowicz
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

8.  Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil.

Authors:  S C Cavalcante; B Durovni; G L Barnes; F B A Souza; R F Silva; P F Barroso; C I Mohan; A Miller; J E Golub; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2010-02       Impact factor: 2.373

9.  The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model.

Authors:  A Roderick Escombe; Clarissa Oeser; Robert H Gilman; Marcos Navincopa; Eduardo Ticona; Carlos Martínez; Luz Caviedes; Patricia Sheen; Armando Gonzalez; Catherine Noakes; David A J Moore; Jon S Friedland; Carlton A Evans
Journal:  Clin Infect Dis       Date:  2007-04-09       Impact factor: 9.079

10.  Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five--year retrospective study.

Authors:  Belay Tessema; Abebe Muche; Assegedech Bekele; Dieter Reissig; Frank Emmrich; Ulrich Sack
Journal:  BMC Public Health       Date:  2009-10-04       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.